Pharmigene, Inc. (7595.TWO)

TWD 13.8

(0.0%)

Annual Balance Sheets

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Total Assets 1.04 Billion 384.26 Million 419.12 Million 449.91 Million 172.22 Million
Total Current Assets 253.98 Million 258.53 Million 286.08 Million 337.07 Million 129.78 Million
Cash And Short Term Investments 181.75 Million 195.59 Million 239.08 Million 297.47 Million 98.32 Million
Cash and Cash Equivalents 68.53 Million 76.86 Million 104.28 Million 212.77 Million 45.32 Million
Short Term Investments 113.22 Million 118.73 Million 134.79 Million 84.7 Million 53 Million
Net Receivables 44.06 Million 33.97 Million 27.99 Million 21.87 Million 9.34 Million
Inventory 27.44 Million 28.57 Million 18.7 Million 17.46 Million 10.15 Million
Other Current Assets 720 Thousand 402 Thousand 301 Thousand 267 Thousand 11.95 Million
Total Non-Current Assets 792.96 Million 125.73 Million 133.03 Million 112.83 Million 42.44 Million
Net PPE 564.12 Million 30.75 Million 36.72 Million 30.56 Million 30.95 Million
Good Will And Intangible Assets 14.06 Million 14.02 Million 15.96 Million 6.3 Million 7.44 Million
Good Will - - - - -
Intangible Assets 14.06 Million 14.02 Million 15.96 Million 6.3 Million 7.44 Million
Long-Term Investments -27.11 Million -51.54 Million -63.99 Million -21.3 Million -
Tax Assets 239.45 Million 129.97 Million 141.48 Million 22 Thousand -
Other Non Current Assets 2.42 Million 2.51 Million 2.84 Million 97.24 Million 4.04 Million
Other Assets - - - - -
Total Liabilities 602.85 Million 44.51 Million 36.89 Million 40.35 Million 41.47 Million
Total Current Liabilities 36.72 Million 38.3 Million 24.84 Million 23.81 Million 26.33 Million
Account Payables 7.94 Million 7.19 Million 2.87 Million 2.88 Million 1.37 Million
Tax Payables - - - 1.48 Million -
Short Term Debt 6.53 Million 5.34 Million 6.99 Million 6.89 Million -
Deferred Revenue 20.44 Million 25.45 Million 14.79 Million 13.93 Million -
Other Current Liabilities 1.79 Million 311 Thousand 180 Thousand 102 Thousand 24.95 Million
Total Non Current Liabilities 566.13 Million 6.21 Million 12.05 Million 16.53 Million 15.14 Million
Long-Term Debt 564.56 Million 4.08 Million 7.74 Million 14.74 Million 13.84 Million
Deferred Revenue Non Current - - - - -
Deferred Tax Liabilities Non Current - - - - -
Other Non Current Liabilities 1.57 Million 2.12 Million 4.29 Million 1.79 Million 1.29 Million
Other Liabilities - - - - -
Total Equity 444.1 Million 339.75 Million 382.22 Million 409.56 Million 130.75 Million
Stock Holders Equity 444.1 Million 339.75 Million 382.22 Million 409.56 Million 130.75 Million
Common Stock 504.65 Million 434.65 Million 434.65 Million 434.65 Million 219.7 Million
Retained Earnings -172.73 Million -100.08 Million -57.37 Million -79 Million -134.89 Million
Accumulated other comprehensive income 7.18 Million 5.18 Million 4.94 Million 8.85 Million -589.99 Thousand
Common Stock Equity 444.1 Million 339.75 Million 382.22 Million 409.56 Million 130.75 Million
Capital Lease Obligation 11.69 Million 9.43 Million 14.74 Million 21.63 Million 18.75 Million
Total Investments 86.1 Million 67.18 Million 70.8 Million 63.4 Million 53 Million
Total Debt 571.09 Million 9.43 Million 14.74 Million 21.63 Million 13.84 Million
Net Debt 502.56 Million -67.42 Million -89.54 Million -191.14 Million -31.48 Million

Balance Sheet Charts